PSIL | AdvisorShares Psychedelics ETF Overview

(Stock Exchange: AMEX)

Day's Range	12.57 - 12.72
52 Week Range	0.8790 - 17.00
Beta	0.88
Implied Volatility	98.78%
IV Rank	12.57%
Day's Volume	4,743
Average Volume	13,050
Shares Outstanding	500,668
Inception Date	2021-09-16

Assets	5,417,200
Asset Class	Equity
Expense Ratio	N/A
P/E Ratio	N/A
EPS	N/A
Dividend Yield	1.71%
Dividend Per Share	0.22
Dividend ExDate	N/A
Dividend PayDate	N/A

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.

*Chart delayed

Watching at PSIL technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on PSIL Technicals page.